Delivery Order SPE2DB24D8001-SPE2DB25FLACR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,425.36 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Jardiance 10 mg tablets (90-count packages). The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed price pricing and carries no set-aside designation. This delivery order represents a continuation of Dakota Drug's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,426.86 to Dakota Drug, Inc. for the supply of Jardiance 25 mg tablets (90-count units) with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-set-aside procurement executed through Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. The contract is valued at up to $999,999,999.00 and runs through...
- The Defense Logistics Agency awarded a $2.74K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Jardiance 25 mg tablets (90-count units). Issued on August 19, 2025, with completion scheduled for August 20, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract contains no...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,766.92, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm-fixed-price delivery order, with an ultimate completion date of July 18, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Armed...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.04 to Dakota Drug, Inc. for the supply of Jardiance 10 mg tablets (90-count) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a continuation of pharmaceutical supply services under the company's larger indefinite delivery contract with DLA Troop Support Medical's ECAT Generation V Program (SPE2DB24D8001), valued at $999,999,999.00 through December 31, 2025. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.04 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on August 21, 2025. The order covers 90 tablets of Jardiance 25 mg, a diabetes management medication, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of Dakota Drug's pharmaceutical supply support to the federal government. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,906.83, is for the delivery of Jardiance 25 mg tablets to support medical supply requirements. The contract is a firm fixed-price, non-set-aside award with a period of performance through November 7, 2023. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,461.21 Firm Fixed Price contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 14, 2023. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLACRDelivery Order
Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order valued at $1,895.71 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and running through December 31, 2025, which was originally established through solicitation SPE2DH-21-R-0002. Dakota Drug, Inc. serves as a critical pharmaceutical supplier to the U.S. Armed Forces medical operations, providing a comprehensive range of medications and medical supplies to military healthcare facilities through the DLA. The company's track record includes delivering diverse pharmaceutical products spanning diabetes management, respiratory medications, pain management drugs, and vaccines to defense healthcare providers. This specific delivery order for Jardiance, a diabetes management medication, exemplifies the company's strategic role in supporting military medical readiness and reflects the ongoing demand for essential pharmaceutical products within the federal defense healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/29/25 |